ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
Dow Jones
42.840,26
1,18%
Euro vs US Dollar
1,043
0,00%
Bitcoin
97.058,46
-0,15%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Eton Pharmaceuticals Inc (ETON) Börsenkurse

Eton Pharmaceuticals Inc

Eton Pharmaceuticals Inc (ETON)

NASDAQ
12,57
0,29
(2,36%)
Geschlossen 22 Dezember 10:00PM
Verzögert um 15 Minuten
12,53
-0,04
(-0,32%)
Nach Börsenschluss: 1:59AM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
12,57
Gebot
8,00
Fragen
14,09
Volumen
279.336
12,21 Tagesbereich 13,29
3,03 52-Wochen-Bereich 13,72
Marktkapitalisierung
324,761M
Handelsende
12,28
Handelsbeginn
12,21
Letzte Trade
1
@
12.56
Letzter Handelszeitpunkt
Finanzvolumen
US$ 3.585.668
VWAP
12,8364
Durchschnittliches Volumen (3 Mio.)
220.914
Ausgegebene Aktien
25.836.204
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-346,13
Gewinn pro Aktie (EPS)
-0,04
Erlöse
31,64M
Nettogewinn
-936k

Über Eton Pharmaceuticals Inc

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eleven product candidates in various stages of development. Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eleven product candidates in various stages of development.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.etonpharma.com
Hauptsitz
Dover, Delaware, USA
Gegründet
-
Eton Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ETON. The last closing price for Eton Pharmaceuticals was US$12,28. Over the last year, Eton Pharmaceuticals shares have traded in a share price range of US$ 3,03 to US$ 13,72.

Eton Pharmaceuticals currently has 25.836.204 shares in issue. The market capitalisation of Eton Pharmaceuticals is US$317,27 million. Eton Pharmaceuticals has a price to earnings ratio (PE ratio) of -346.13.

ETON Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report

20 Dezember 2024
Edgar (US Regulatory)

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

Acquisition bolsters Eton’s commercial pediatric endocrinology portfolioProduct is now available through AnovoRx, a specialty pharmacy dedicated to serving patients with rare and chronic...

20 Dezember 2024
GlobeNewswire Inc.

Form 8-K - Current report

17 Dezember 2024
Edgar (US Regulatory)

Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial

DEER PARK, Ill., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and...

17 Dezember 2024
GlobeNewswire Inc.

Form 8-K - Current report

12 Dezember 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

12 Dezember 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

09 Dezember 2024
Edgar (US Regulatory)

Form 8-K - Current report

03 Dezember 2024
Edgar (US Regulatory)

Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer

Ms. Erdogan-Trinkaus brings a wealth of commercial leadership and expertise in sales and marketing from her tenure at leading global pharmaceutical companies and across the broader health and...

03 Dezember 2024
GlobeNewswire Inc.

Form 8-K - Current report

25 November 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.352.8641571194812.2213.0111.814796112.44079541CS
41.7816.496756255810.7913.7210.622870012.26940444CS
126.87120.5263157895.713.725.632209149.85429216CS
269.27280.9090909093.313.723.181472848.19339013CS
528.01175.6578947374.5613.723.031064686.95672247CS
1568.46205.8394160584.1113.721.951349914.50685375CS
2606.0693.08755760376.5113.721.952070675.80218438CS

ETON - Frequently Asked Questions (FAQ)

What is the current Eton Pharmaceuticals share price?
The current share price of Eton Pharmaceuticals is US$ 12,57
How many Eton Pharmaceuticals shares are in issue?
Eton Pharmaceuticals has 25.836.204 shares in issue
What is the market cap of Eton Pharmaceuticals?
The market capitalisation of Eton Pharmaceuticals is USD 317,27M
What is the 1 year trading range for Eton Pharmaceuticals share price?
Eton Pharmaceuticals has traded in the range of US$ 3,03 to US$ 13,72 during the past year
What is the PE ratio of Eton Pharmaceuticals?
The price to earnings ratio of Eton Pharmaceuticals is -346,13
What is the cash to sales ratio of Eton Pharmaceuticals?
The cash to sales ratio of Eton Pharmaceuticals is 10,23
What is the reporting currency for Eton Pharmaceuticals?
Eton Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Eton Pharmaceuticals?
The latest annual turnover of Eton Pharmaceuticals is USD 31,64M
What is the latest annual profit for Eton Pharmaceuticals?
The latest annual profit of Eton Pharmaceuticals is USD -936k
What is the registered address of Eton Pharmaceuticals?
The registered address for Eton Pharmaceuticals is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the Eton Pharmaceuticals website address?
The website address for Eton Pharmaceuticals is www.etonpharma.com
Which industry sector does Eton Pharmaceuticals operate in?
Eton Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,5M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,63M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,84M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
8,58M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
5,96M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,33M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
310,19M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
306,25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
293,22M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
281,23M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
ETON
Eton Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten